Sebastian Carotta

Sebastian Carotta

Company: Boehringer Ingelheim

Job title: Scientific Director, Cancer Cell Signalling

Seminars:

Speaker Q&A 5:05 pm

Read more

day: Day One

Mode of Action in STING Agonists to Identify Rational Combinations 4:40 pm

STING pathway agonists are highly attractive for cancer immunotherapy as they are potent innate immune cell activators For successful STING therapy, several challenges need to be addressed: bell-shaped dose-efficacy relationship, potentially limited numbers of injections possible, in cold tumor STING Ag treatment might not be sufficient to induce strong enough CD8+ T cell infiltration for…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.